ATC codes:
N05CD08
EMLc
Indication
Status epilepticus
ICD11 code:
8A66
INN
Midazolam
Medicine type
Chemical agent
List type
Core
Additional notes
Midazolam injection may be used for buccal administration when solution for oromucosal administration is not available.
Formulations
Parenteral > General injections > unspecified:
1 mg per mL in 5 mL vial (for buccal administration) ;
5 mg per mL in 1 mL vial (for buccal administration) ;
5 mg per mL in 3 mL vial (for buccal administration)
Local > Buccal > Solution: 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.75 mL pre-filled syringe ; 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration)
Local > Buccal > Solution: 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.75 mL pre-filled syringe ; 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended amendments to the listing for midazolam for status epilepticus on the EML and EMLc to better describe the available dosage forms.